
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="The most comprehensive guide to building a $50K-$100K/month cybersecurity consulting practice">
      
      
        <meta name="author" content="Security Consulting Guide">
      
      
        <link rel="canonical" href="https://ahmed-adelb.github.io/security-consulting-income-guide/raw-data/codex-research/CODEX_PHARMA_BIOTECH_10K/">
      
      
      
      
        
      
      
      <link rel="icon" href="../../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>CODEX 10K RESEARCH: Pharmaceutical & Biotech Security Consulting Guide - Security Consulting Income Guide</title>
      
    
    
      <link rel="stylesheet" href="../../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../../stylesheets/extra.css">
    
    <script>__md_scope=new URL("../../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="slate" data-md-color-primary="deep-purple" data-md-color-accent="amber">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#codex-10k-research-pharmaceutical-biotech-security-consulting-guide" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow md-header--lifted" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../../.." title="Security Consulting Income Guide" class="md-header__button md-logo" aria-label="Security Consulting Income Guide" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Security Consulting Income Guide
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              CODEX 10K RESEARCH: Pharmaceutical &amp; Biotech Security Consulting Guide
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="deep-purple" data-md-color-accent="amber"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="deep-purple" data-md-color-accent="amber"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
          <a href="javascript:void(0)" class="md-search__icon md-icon" title="Share" aria-label="Share" data-clipboard data-clipboard-text="" data-md-component="search-share" tabindex="-1">
            
            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M18 16.08c-.76 0-1.44.3-1.96.77L8.91 12.7c.05-.23.09-.46.09-.7s-.04-.47-.09-.7l7.05-4.11c.54.5 1.25.81 2.04.81a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3c0 .24.04.47.09.7L8.04 9.81C7.5 9.31 6.79 9 6 9a3 3 0 0 0-3 3 3 3 0 0 0 3 3c.79 0 1.5-.31 2.04-.81l7.12 4.15c-.05.21-.08.43-.08.66 0 1.61 1.31 2.91 2.92 2.91s2.92-1.3 2.92-2.91A2.92 2.92 0 0 0 18 16.08"/></svg>
          </a>
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/Ahmed-AdelB/security-consulting-income-guide" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    Ahmed-AdelB/security-consulting-income-guide
  </div>
</a>
      </div>
    
  </nav>
  
    
      
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
  
    <li class="md-tabs__item">
      <a href="../../.." class="md-tabs__link">
        
  
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../platforms/" class="md-tabs__link">
          
  
  
  Platforms

        </a>
      </li>
    
  

      
        
  
  
  
  
    <li class="md-tabs__item">
      <a href="../../../domains/" class="md-tabs__link">
        
  
  
    
  
  Security Domains

      </a>
    </li>
  

      
        
  
  
  
  
    <li class="md-tabs__item">
      <a href="../../../industries/" class="md-tabs__link">
        
  
  
    
  
  Industries

      </a>
    </li>
  

      
        
  
  
  
  
    <li class="md-tabs__item">
      <a href="../../../income-streams/" class="md-tabs__link">
        
  
  
    
  
  Income Streams

      </a>
    </li>
  

      
        
  
  
  
  
    <li class="md-tabs__item">
      <a href="../../../getting-started/" class="md-tabs__link">
        
  
  
    
  
  Getting Started

      </a>
    </li>
  

      
        
  
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../market-research/" class="md-tabs__link">
          
  
  
  Market Research

        </a>
      </li>
    
  

      
        
  
  
  
  
    <li class="md-tabs__item">
      <a href="../../" class="md-tabs__link">
        
  
  
    
  
  Raw Data

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
    
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../../.." title="Security Consulting Income Guide" class="md-nav__button md-logo" aria-label="Security Consulting Income Guide" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Security Consulting Income Guide
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/Ahmed-AdelB/security-consulting-income-guide" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    Ahmed-AdelB/security-consulting-income-guide
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_2" >
        
          
          <label class="md-nav__link" for="__nav_2" id="__nav_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Platforms
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Platforms
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../platforms/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../platforms/expert-networks/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Expert Networks
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../platforms/bug-bounty/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bug Bounty
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../platforms/vciso/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    vCISO
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../platforms/expert-witness/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Expert Witness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../platforms/web3-audit/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Web3 Audit
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../domains/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Security Domains
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../industries/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Industries
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../income-streams/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Income Streams
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../getting-started/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Getting Started
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_7" >
        
          
          <label class="md-nav__link" for="__nav_7" id="__nav_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Market Research
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Market Research
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../market-research/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../market-research/salary-benchmarks/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Salary Benchmarks
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../market-research/platform-reviews/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Platform Reviews
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../market-research/community-insights/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Community Insights
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../../market-research/rate-guides/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rate Guides
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Raw Data
  

    
  </span>
  
  

      </a>
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#scope-methodology-and-limitations" class="md-nav__link">
    <span class="md-ellipsis">
      
        Scope, Methodology, and Limitations
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#source-index-internal-repository" class="md-nav__link">
    <span class="md-ellipsis">
      
        Source Index (Internal Repository)
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#executive-summary" class="md-nav__link">
    <span class="md-ellipsis">
      
        Executive Summary
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#table-of-contents" class="md-nav__link">
    <span class="md-ellipsis">
      
        Table of Contents
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#1-market-overview-demand-drivers" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. Market Overview &amp; Demand Drivers
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="1. Market Overview &amp; Demand Drivers">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#11-demand-drivers" class="md-nav__link">
    <span class="md-ellipsis">
      
        1.1 Demand Drivers
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#12-buyer-personas-stakeholders" class="md-nav__link">
    <span class="md-ellipsis">
      
        1.2 Buyer Personas &amp; Stakeholders
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#13-industry-segments-environments" class="md-nav__link">
    <span class="md-ellipsis">
      
        1.3 Industry Segments &amp; Environments
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#14-pricing-premiums-economic-signals" class="md-nav__link">
    <span class="md-ellipsis">
      
        1.4 Pricing Premiums &amp; Economic Signals
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-threat-landscape-risk-economics" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. Threat Landscape &amp; Risk Economics
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="2. Threat Landscape &amp; Risk Economics">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#21-core-threat-vectors" class="md-nav__link">
    <span class="md-ellipsis">
      
        2.1 Core Threat Vectors
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#22-risk-economics-and-business-impact" class="md-nav__link">
    <span class="md-ellipsis">
      
        2.2 Risk Economics and Business Impact
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#23-threat-landscape-implications-for-consulting" class="md-nav__link">
    <span class="md-ellipsis">
      
        2.3 Threat Landscape Implications for Consulting
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-regulatory-compliance-alignment-hipaa-gxp-irb" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. Regulatory &amp; Compliance Alignment (HIPAA, GxP, IRB)
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="3. Regulatory &amp; Compliance Alignment (HIPAA, GxP, IRB)">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#31-regulatory-stack-referenced-in-internal-sources" class="md-nav__link">
    <span class="md-ellipsis">
      
        3.1 Regulatory Stack Referenced in Internal Sources
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#32-hipaa-update-signals-internal-2025-notes" class="md-nav__link">
    <span class="md-ellipsis">
      
        3.2 HIPAA Update Signals (Internal 2025 Notes)
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#33-fda-adjacent-compliance-signals-gxp-irb" class="md-nav__link">
    <span class="md-ellipsis">
      
        3.3 FDA-Adjacent Compliance Signals (GxP / IRB)
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#34-compliance-evidence-expectations" class="md-nav__link">
    <span class="md-ellipsis">
      
        3.4 Compliance Evidence Expectations
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#35-consultant-translation-layer" class="md-nav__link">
    <span class="md-ellipsis">
      
        3.5 Consultant Translation Layer
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-data-inventory-classification-and-ip-protection" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. Data Inventory, Classification, and IP Protection
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="4. Data Inventory, Classification, and IP Protection">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#41-sensitive-data-types-in-pharmabiotech" class="md-nav__link">
    <span class="md-ellipsis">
      
        4.1 Sensitive Data Types in Pharma/Biotech
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#42-ip-protection-drivers-from-internal-research" class="md-nav__link">
    <span class="md-ellipsis">
      
        4.2 IP Protection Drivers from Internal Research
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#43-data-classification-and-handling-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        4.3 Data Classification and Handling Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#44-ip-protection-engagement-deliverables" class="md-nav__link">
    <span class="md-ellipsis">
      
        4.4 IP Protection Engagement Deliverables
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-governance-grc-program-design" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. Governance &amp; GRC Program Design
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="5. Governance &amp; GRC Program Design">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#51-governance-structure" class="md-nav__link">
    <span class="md-ellipsis">
      
        5.1 Governance Structure
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#52-core-grc-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        5.2 Core GRC Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#53-evidence-management" class="md-nav__link">
    <span class="md-ellipsis">
      
        5.3 Evidence Management
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-research-lab-and-clinical-trial-security" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. Research, Lab, and Clinical Trial Security
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="6. Research, Lab, and Clinical Trial Security">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#61-lab-and-research-security-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        6.1 Lab and Research Security Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#62-clinical-trial-data-integrity" class="md-nav__link">
    <span class="md-ellipsis">
      
        6.2 Clinical Trial Data Integrity
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#63-clinical-research-ecosystem-management" class="md-nav__link">
    <span class="md-ellipsis">
      
        6.3 Clinical Research Ecosystem Management
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-manufacturing-otics-security-for-pharma-plants" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. Manufacturing &amp; OT/ICS Security for Pharma Plants
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="7. Manufacturing &amp; OT/ICS Security for Pharma Plants">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#71-otics-context-for-pharma" class="md-nav__link">
    <span class="md-ellipsis">
      
        7.1 OT/ICS Context for Pharma
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#72-otics-security-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        7.2 OT/ICS Security Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#73-pharma-manufacturing-positioning" class="md-nav__link">
    <span class="md-ellipsis">
      
        7.3 Pharma Manufacturing Positioning
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-supply-chain-logistics-security-for-high-value-shipments" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. Supply Chain &amp; Logistics Security for High-Value Shipments
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="8. Supply Chain &amp; Logistics Security for High-Value Shipments">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#81-supply-chain-threat-signals" class="md-nav__link">
    <span class="md-ellipsis">
      
        8.1 Supply Chain Threat Signals
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#82-supply-chain-security-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        8.2 Supply Chain Security Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#83-consulting-opportunities" class="md-nav__link">
    <span class="md-ellipsis">
      
        8.3 Consulting Opportunities
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#9-cloud-api-and-application-security-in-life-sciences" class="md-nav__link">
    <span class="md-ellipsis">
      
        9. Cloud, API, and Application Security in Life Sciences
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="9. Cloud, API, and Application Security in Life Sciences">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#91-cloud-security-in-rd" class="md-nav__link">
    <span class="md-ellipsis">
      
        9.1 Cloud Security in R&amp;D
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#92-api-security-and-industry-premiums" class="md-nav__link">
    <span class="md-ellipsis">
      
        9.2 API Security and Industry Premiums
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#93-application-security-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        9.3 Application Security Controls
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#10-incident-response-ransomware-resilience" class="md-nav__link">
    <span class="md-ellipsis">
      
        10. Incident Response &amp; Ransomware Resilience
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="10. Incident Response &amp; Ransomware Resilience">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#101-incident-response-foundations" class="md-nav__link">
    <span class="md-ellipsis">
      
        10.1 Incident Response Foundations
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#102-ransomware-resilience" class="md-nav__link">
    <span class="md-ellipsis">
      
        10.2 Ransomware Resilience
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#103-consulting-service-opportunities" class="md-nav__link">
    <span class="md-ellipsis">
      
        10.3 Consulting Service Opportunities
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#11-third-party-risk-management-vendor-governance" class="md-nav__link">
    <span class="md-ellipsis">
      
        11. Third-Party Risk Management &amp; Vendor Governance
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="11. Third-Party Risk Management &amp; Vendor Governance">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#111-vendor-risk-drivers" class="md-nav__link">
    <span class="md-ellipsis">
      
        11.1 Vendor Risk Drivers
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#112-vendor-risk-program-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        11.2 Vendor Risk Program Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#113-vendor-audit-offerings" class="md-nav__link">
    <span class="md-ellipsis">
      
        11.3 Vendor Audit Offerings
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#12-ma-and-due-diligence-in-pharmabiotech" class="md-nav__link">
    <span class="md-ellipsis">
      
        12. M&amp;A and Due Diligence in Pharma/Biotech
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="12. M&amp;A and Due Diligence in Pharma/Biotech">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#121-diligence-pricing-signals" class="md-nav__link">
    <span class="md-ellipsis">
      
        12.1 Diligence Pricing Signals
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#122-diligence-evidence-checklist" class="md-nav__link">
    <span class="md-ellipsis">
      
        12.2 Diligence Evidence Checklist
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#123-post-close-integration-focus" class="md-nav__link">
    <span class="md-ellipsis">
      
        12.3 Post-Close Integration Focus
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#13-engagement-models-deliverable-packages" class="md-nav__link">
    <span class="md-ellipsis">
      
        13. Engagement Models &amp; Deliverable Packages
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="13. Engagement Models &amp; Deliverable Packages">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#131-common-engagement-structures" class="md-nav__link">
    <span class="md-ellipsis">
      
        13.1 Common Engagement Structures
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#132-healthcare-benchmark-packages-adaptable-to-life-sciences" class="md-nav__link">
    <span class="md-ellipsis">
      
        13.2 Healthcare Benchmark Packages (Adaptable to Life Sciences)
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#133-standard-deliverables" class="md-nav__link">
    <span class="md-ellipsis">
      
        13.3 Standard Deliverables
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#14-rate-pricing-benchmarks" class="md-nav__link">
    <span class="md-ellipsis">
      
        14. Rate &amp; Pricing Benchmarks
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="14. Rate &amp; Pricing Benchmarks">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#141-hourly-rate-benchmarks-healthcare-baseline" class="md-nav__link">
    <span class="md-ellipsis">
      
        14.1 Hourly Rate Benchmarks (Healthcare Baseline)
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#142-industry-premium-signals" class="md-nav__link">
    <span class="md-ellipsis">
      
        14.2 Industry Premium Signals
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#143-expert-network-rate-signals-life-sciences" class="md-nav__link">
    <span class="md-ellipsis">
      
        14.3 Expert Network Rate Signals (Life Sciences)
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#144-specialist-network-benchmarks" class="md-nav__link">
    <span class="md-ellipsis">
      
        14.4 Specialist Network Benchmarks
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#15-expert-networks-sme-sourcing" class="md-nav__link">
    <span class="md-ellipsis">
      
        15. Expert Networks &amp; SME Sourcing
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="15. Expert Networks &amp; SME Sourcing">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#151-life-sciences-focused-networks" class="md-nav__link">
    <span class="md-ellipsis">
      
        15.1 Life Sciences-Focused Networks
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#152-platforms-to-avoid-for-cybersecurity-focus" class="md-nav__link">
    <span class="md-ellipsis">
      
        15.2 Platforms to Avoid for Cybersecurity Focus
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#153-platform-insight-highlights" class="md-nav__link">
    <span class="md-ellipsis">
      
        15.3 Platform Insight Highlights
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#16-positioning-messaging-and-go-to-market" class="md-nav__link">
    <span class="md-ellipsis">
      
        16. Positioning, Messaging, and Go-To-Market
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="16. Positioning, Messaging, and Go-To-Market">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#161-positioning-angles" class="md-nav__link">
    <span class="md-ellipsis">
      
        16.1 Positioning Angles
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#162-messaging-themes" class="md-nav__link">
    <span class="md-ellipsis">
      
        16.2 Messaging Themes
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#163-sales-channels" class="md-nav__link">
    <span class="md-ellipsis">
      
        16.3 Sales Channels
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#17-metrics-kpis-and-evidence-tracking" class="md-nav__link">
    <span class="md-ellipsis">
      
        17. Metrics, KPIs, and Evidence Tracking
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="17. Metrics, KPIs, and Evidence Tracking">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#171-compliance-and-security-kpis" class="md-nav__link">
    <span class="md-ellipsis">
      
        17.1 Compliance and Security KPIs
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#172-evidence-tracking-practices" class="md-nav__link">
    <span class="md-ellipsis">
      
        17.2 Evidence Tracking Practices
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#18-306090-day-execution-plan" class="md-nav__link">
    <span class="md-ellipsis">
      
        18. 30/60/90-Day Execution Plan
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="18. 30/60/90-Day Execution Plan">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#181-first-30-days" class="md-nav__link">
    <span class="md-ellipsis">
      
        18.1 First 30 Days
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#182-days-3160" class="md-nav__link">
    <span class="md-ellipsis">
      
        18.2 Days 31–60
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#183-days-6190" class="md-nav__link">
    <span class="md-ellipsis">
      
        18.3 Days 61–90
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#19-appendix-a-pharmabiotech-control-checklist" class="md-nav__link">
    <span class="md-ellipsis">
      
        19. Appendix A: Pharma/Biotech Control Checklist
      
    </span>
  </a>
  
    <nav class="md-nav" aria-label="19. Appendix A: Pharma/Biotech Control Checklist">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#191-governance-policy-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.1 Governance &amp; Policy Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#192-identity-access-management" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.2 Identity &amp; Access Management
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#193-data-protection-ip-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.3 Data Protection &amp; IP Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#194-network-segmentation" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.4 Network &amp; Segmentation
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#195-endpoint-device-security" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.5 Endpoint &amp; Device Security
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#196-application-api-security" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.6 Application &amp; API Security
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#197-otics-security-controls" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.7 OT/ICS Security Controls
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#198-clinical-trial-security" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.8 Clinical Trial Security
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#199-vendor-third-party-risk" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.9 Vendor &amp; Third-Party Risk
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#1910-incident-response-resilience" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.10 Incident Response &amp; Resilience
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#1911-physical-facility-security" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.11 Physical &amp; Facility Security
      
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#1912-training-awareness" class="md-nav__link">
    <span class="md-ellipsis">
      
        19.12 Training &amp; Awareness
      
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#20-appendix-b-evidence-pack-templates" class="md-nav__link">
    <span class="md-ellipsis">
      
        20. Appendix B: Evidence Pack Templates
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#21-appendix-c-source-map-and-notes" class="md-nav__link">
    <span class="md-ellipsis">
      
        21. Appendix C: Source Map and Notes
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  


  
  


<h1 id="codex-10k-research-pharmaceutical-biotech-security-consulting-guide">CODEX 10K RESEARCH: Pharmaceutical &amp; Biotech Security Consulting Guide<a class="headerlink" href="#codex-10k-research-pharmaceutical-biotech-security-consulting-guide" title="Permanent link">&para;</a></h1>
<p><strong>Research scale:</strong> "Massive 10K" synthesis of internal repository data.
<strong>Focus:</strong> Pharmaceutical, biotechnology, and life sciences security consulting.
<strong>Core themes:</strong> Regulatory alignment, IP protection, operational resilience, and revenue models.
<strong>Limitations:</strong> No external browsing; validate with regulators, clients, and legal counsel.</p>
<h2 id="scope-methodology-and-limitations">Scope, Methodology, and Limitations<a class="headerlink" href="#scope-methodology-and-limitations" title="Permanent link">&para;</a></h2>
<p>This guide synthesizes pharma/biotech security consulting signals from internal research assets.
It blends healthcare HIPAA research, GRC compliance guidance, OT/ICS security, and expert network pricing data.
The output is optimized for consultants building services, proposals, and pricing in life sciences environments.
It is not legal advice or a substitute for formal regulatory counsel.</p>
<p><strong>Focus areas:</strong>
- Pharma and biotech R&amp;D security, clinical trial integrity, and lab operations.
- GxP and IRB compliance expectations referenced in internal datasets.
- Healthcare and life sciences rate benchmarks and industry premiums.
- IP protection and trade secret safeguarding in regulated R&amp;D programs.
- Manufacturing and OT/ICS security for pharma production environments.
- Supply chain security for high-value, temperature-controlled shipments.
- Expert network positioning and SME sourcing for life sciences projects.</p>
<p><strong>Interpretation rules used here:</strong>
- "Rates" refer to internal benchmarks and should be validated per engagement.
- "Premium" denotes observed uplifts in internal rate and salary research.
- "Compliance" refers to requirements surfaced in internal sources (HIPAA, GxP, IRB).
- "IP protection" is treated as a core business driver in pharma/biotech security.</p>
<p><strong>Non-legal notice:</strong> This document is not legal advice. Regulations require formal legal interpretation.</p>
<h2 id="source-index-internal-repository">Source Index (Internal Repository)<a class="headerlink" href="#source-index-internal-repository" title="Permanent link">&para;</a></h2>
<p>Primary internal sources referenced in this guide:
- <code>CODEX_HEALTHCARE_10K.md</code>
- <code>HEALTHCARE_SECURITY_CONSULTING_GUIDE_2025.md</code>
- <code>CODEX_API_SECURITY_10K.md</code>
- <code>CODEX_MA_DUEDILIGENCE_10K.md</code>
- <code>CODEX_OT_SECURITY_10K.md</code>
- <code>CODEX_MANUFACTURING_ICS_5K.md</code>
- <code>CODEX_LOGISTICS_SUPPLY_CHAIN_5K.md</code>
- <code>GRC_COMPLIANCE_CONSULTING_COMPREHENSIVE_INCOME_GUIDE_2025.md</code>
- <code>PAYSCALE_SECURITY_SALARY_RESEARCH_2025.md</code>
- <code>SECURITY_CONSULTING_SALARY_RESEARCH_2025.md</code>
- <code>EXPERT_NETWORK_COMPREHENSIVE_RESEARCH_2025.md</code>
- <code>REDDIT_EXPERT_NETWORK_COMPREHENSIVE_ANALYSIS_2025.md</code>
- <code>expert-network-research-2024-2025.json</code>
- <code>List of Expert Consulting Platforms for Cybersecurity Professionals/MASTER_EXPERT_NETWORKS_COMPLETE_DOCUMENT.md</code>
- <code>List of Expert Consulting Platforms for Cybersecurity Professionals/COMPLETE_MERGED_EXPERT_NETWORKS_REPORT.md</code>
- <code>List of Expert Consulting Platforms for Cybersecurity Professionals/Expert Network Platforms for Cybersecurity Consulting.md</code>
- <code>List of Expert Consulting Platforms for Cybersecurity Professionals/research_expert_networks.csv</code>
- <code>List of Expert Consulting Platforms for Cybersecurity Professionals/pasted_content_2.txt</code>
- <code>List of Expert Consulting Platforms for Cybersecurity Professionals/pasted_content_3.txt</code>
- <code>docs/PART3_PLATFORMS_TO_AVOID.md</code>
- <code>retainer_extracts.txt</code>
- <code>CODEX_PRIVACY_10K.md</code>
- <code>CODEX_AI_SECURITY_10K.md</code>
- <code>CODEX_SECURITY_ARCH_10K.md</code>
- <code>CODEX_THREAT_INTEL_10K.md</code></p>
<h2 id="executive-summary">Executive Summary<a class="headerlink" href="#executive-summary" title="Permanent link">&para;</a></h2>
<ul>
<li>Pharma/biotech security commands premium compensation driven by IP protection and regulatory pressure.</li>
<li>Internal pay data lists pharmaceutical &amp; biotechnology median pay at $203,846 in multiple salary sources.</li>
<li>Industry premiums for pharma/biotech are cited at +26% to +50% due to IP protection and R&amp;D security needs.</li>
<li>Healthcare/life sciences API security work carries a +10–30% premium in internal API rate research.</li>
<li>M&amp;A due diligence for healthcare/life sciences adds 20–70% for PHI and compliance checks.</li>
<li>HIPAA update signals include Zero Trust expectations, universal MFA, and 30-day breach notification timelines.</li>
<li>Internal GRC sources list pharma and medical devices as high-demand compliance industries.</li>
<li>GxP compliance and IRB oversight appear in expert network data, indicating life sciences-specific obligations.</li>
<li>IP protection is a recurring driver in internal data (trade secrets, model IP, deliverable ownership).</li>
<li>Pharma manufacturing environments fall under OT/ICS security scope with safety-first constraints.</li>
<li>Supply chain security research flags a 40% YoY rise in cargo theft for high-value goods like pharma.</li>
<li>Expert networks cite very high demand for healthcare and pharma SMEs with $100–$1,000+/hour rates.</li>
<li>Techspert is positioned as a healthcare/life sciences specialist with reported ~200€/hour rates.</li>
<li>Expert network data emphasizes niche specialization (biotech expertise) as a premium positioning lever.</li>
<li>HIPAA readiness assessments range $3K–$60K+ with vCISO retainers $2.5K–$20K+/mo.</li>
<li>Pharma/biotech security programs must align operational risk, regulatory evidence, and IP safeguards.</li>
</ul>
<h2 id="table-of-contents">Table of Contents<a class="headerlink" href="#table-of-contents" title="Permanent link">&para;</a></h2>
<ol>
<li>Market Overview &amp; Demand Drivers</li>
<li>Threat Landscape &amp; Risk Economics</li>
<li>Regulatory &amp; Compliance Alignment (HIPAA, GxP, IRB)</li>
<li>Data Inventory, Classification, and IP Protection</li>
<li>Governance &amp; GRC Program Design</li>
<li>Research, Lab, and Clinical Trial Security</li>
<li>Manufacturing &amp; OT/ICS Security for Pharma Plants</li>
<li>Supply Chain &amp; Logistics Security for High-Value Shipments</li>
<li>Cloud, API, and Application Security in Life Sciences</li>
<li>Incident Response &amp; Ransomware Resilience</li>
<li>Third-Party Risk Management &amp; Vendor Governance</li>
<li>M&amp;A and Due Diligence in Pharma/Biotech</li>
<li>Engagement Models &amp; Deliverable Packages</li>
<li>Rate &amp; Pricing Benchmarks</li>
<li>Expert Networks &amp; SME Sourcing</li>
<li>Positioning, Messaging, and Go-To-Market</li>
<li>Metrics, KPIs, and Evidence Tracking</li>
<li>30/60/90-Day Execution Plan</li>
<li>Appendix A: Pharma/Biotech Control Checklist</li>
<li>Appendix B: Evidence Pack Templates</li>
<li>Appendix C: Source Map and Notes</li>
</ol>
<h2 id="1-market-overview-demand-drivers">1. Market Overview &amp; Demand Drivers<a class="headerlink" href="#1-market-overview-demand-drivers" title="Permanent link">&para;</a></h2>
<h3 id="11-demand-drivers">1.1 Demand Drivers<a class="headerlink" href="#11-demand-drivers" title="Permanent link">&para;</a></h3>
<ul>
<li>IP protection is a leading market driver in pharma/biotech security compensation research.</li>
<li>Regulatory compliance needs (HIPAA, GxP, IRB) increase baseline security spend.</li>
<li>R&amp;D security for drug discovery, biologics, and clinical trial data drives premium consulting demand.</li>
<li>Manufacturing uptime and safety requirements amplify OT/ICS security needs.</li>
<li>Healthcare breach cost signals ($9.77M–$10.93M) reinforce ROI on prevention.</li>
<li>HHS HIPAA updates push demand for Zero Trust and MFA programs.</li>
<li>Vendor risk and third-party liability are increasing across life sciences ecosystems.</li>
<li>M&amp;A activity in biotech increases demand for security diligence and evidence packaging.</li>
<li>Expert network usage in life sciences is high for investment and market research projects.</li>
<li>Cargo theft risk for high-value pharma shipments elevates supply chain security budgets.</li>
<li>Cloud adoption in clinical and lab workloads increases exposure to API and data risks.</li>
<li>Scarcity of OT/ICS talent leads to premium rates in manufacturing facilities.</li>
<li>Specialized expert networks (Techspert, Alacrita) highlight life sciences expertise scarcity.</li>
<li>Compliance penalties (up to $1.9M/year in internal GRC sources) magnify risk.</li>
<li>Insurer requirements (EDR, immutable backups) drive consulting engagements.</li>
</ul>
<h3 id="12-buyer-personas-stakeholders">1.2 Buyer Personas &amp; Stakeholders<a class="headerlink" href="#12-buyer-personas-stakeholders" title="Permanent link">&para;</a></h3>
<ul>
<li>Chief Information Security Officers in pharma/biotech enterprises.</li>
<li>Compliance officers handling HIPAA, GxP, and audit readiness obligations.</li>
<li>Clinical operations and trial leaders overseeing sensitive research data.</li>
<li>Plant managers responsible for production uptime and safety systems.</li>
<li>Supply chain security teams focused on cold-chain logistics.</li>
<li>R&amp;D leadership protecting proprietary formulas and lab data.</li>
<li>Legal teams managing trade secrets, IP clauses, and breach response.</li>
<li>Investor relations teams preparing evidence for diligence reviews.</li>
<li>Vendor management teams enforcing security requirements in contracts.</li>
<li>IT/OT convergence teams managing plant network segmentation.</li>
</ul>
<h3 id="13-industry-segments-environments">1.3 Industry Segments &amp; Environments<a class="headerlink" href="#13-industry-segments-environments" title="Permanent link">&para;</a></h3>
<ul>
<li>Pharmaceutical R&amp;D labs (drug discovery, formulation, bioinformatics).</li>
<li>Biotech startups with cloud-native research stacks.</li>
<li>Contract research organizations (CROs) supporting clinical trials.</li>
<li>Contract manufacturing organizations (CMOs) running production plants.</li>
<li>Medical device manufacturers with regulatory quality systems.</li>
<li>Diagnostics and testing labs handling sensitive patient data.</li>
<li>Digital health and clinical software vendors working with PHI.</li>
<li>Distribution and cold-chain logistics providers for pharma shipments.</li>
<li>Academia and research hospitals partnering on trials.</li>
<li>Investor-backed companies preparing for IPO or acquisition.</li>
</ul>
<h3 id="14-pricing-premiums-economic-signals">1.4 Pricing Premiums &amp; Economic Signals<a class="headerlink" href="#14-pricing-premiums-economic-signals" title="Permanent link">&para;</a></h3>
<ul>
<li>Pharma/biotech compensation leads IT sector by 26% in internal salary research.</li>
<li>Industry premium analysis lists pharma/biotech at +26% to +50% over baseline.</li>
<li>Healthcare/life sciences API security premiums are +10–30% in internal rate data.</li>
<li>Healthcare/life sciences M&amp;A diligence adds 20–70% due to compliance checks.</li>
<li>Expert network rates in healthcare/pharma range widely ($100–$1,000+/hour).</li>
<li>vCISO retainers in healthcare range $2.5K–$20K+/mo; similar expectations apply to life sciences.</li>
<li>HIPAA readiness assessments range $3K–$60K+ depending on organization size.</li>
<li>Medical device inventory audits are cited at $10K+ in healthcare research.</li>
<li>Ransomware resilience audits run ~$7.5K in internal healthcare data.</li>
<li>Incident response and DFIR rates reach $175–$650+/hour in internal datasets.</li>
</ul>
<h2 id="2-threat-landscape-risk-economics">2. Threat Landscape &amp; Risk Economics<a class="headerlink" href="#2-threat-landscape-risk-economics" title="Permanent link">&para;</a></h2>
<h3 id="21-core-threat-vectors">2.1 Core Threat Vectors<a class="headerlink" href="#21-core-threat-vectors" title="Permanent link">&para;</a></h3>
<ul>
<li>Ransomware disrupting clinical systems and manufacturing environments.</li>
<li>IP theft targeting drug formulas, biologics, and proprietary processes.</li>
<li>Insider threats from staff with access to lab systems and research data.</li>
<li>Credential misuse in shared lab accounts and legacy OT environments.</li>
<li>Supply chain compromises affecting software dependencies and vendors.</li>
<li>Data exfiltration via APIs and cloud storage misconfigurations.</li>
<li>Unpatched legacy systems in lab instruments and plant equipment.</li>
<li>Phishing and credential harvesting targeting clinical staff and executives.</li>
<li>OT/IT convergence risks enabling lateral movement into plant networks.</li>
<li>Third-party breaches involving CROs, CMOs, and analytics vendors.</li>
<li>Model theft and data poisoning risks for ML-driven R&amp;D pipelines.</li>
<li>Physical theft of laptops, lab notebooks, or portable devices.</li>
<li>Business email compromise targeting procurement and payments.</li>
<li>Unauthorized remote access via vendor support channels.</li>
<li>Misconfigured backups leading to extended downtime.</li>
</ul>
<h3 id="22-risk-economics-and-business-impact">2.2 Risk Economics and Business Impact<a class="headerlink" href="#22-risk-economics-and-business-impact" title="Permanent link">&para;</a></h3>
<ul>
<li>Breach costs in healthcare contexts are cited at $9.77M–$10.93M.</li>
<li>Regulatory penalties can exceed $1.9M/year for compliance failures.</li>
<li>Clinical trial delays can cascade into missed milestones and revenue loss.</li>
<li>Manufacturing downtime impacts drug supply, patient access, and brand trust.</li>
<li>IP loss erodes competitive advantage and investor confidence.</li>
<li>M&amp;A valuation discounts occur when security evidence is weak.</li>
<li>Insurance premium increases follow significant incidents or control gaps.</li>
<li>Reputational damage affects partner relationships and clinical recruitment.</li>
<li>Data integrity failures threaten trial validity and regulatory approval.</li>
<li>Supply chain disruptions compound losses across distribution partners.</li>
</ul>
<h3 id="23-threat-landscape-implications-for-consulting">2.3 Threat Landscape Implications for Consulting<a class="headerlink" href="#23-threat-landscape-implications-for-consulting" title="Permanent link">&para;</a></h3>
<ul>
<li>Risk quantification must align with R&amp;D and production timelines.</li>
<li>Controls must protect both digital assets and regulated evidence trails.</li>
<li>OT/ICS engagements require safety-first processes and minimal disruption.</li>
<li>Consultants should translate technical risk into business impact metrics.</li>
<li>IP protection should be framed as revenue protection, not just compliance.</li>
</ul>
<h2 id="3-regulatory-compliance-alignment-hipaa-gxp-irb">3. Regulatory &amp; Compliance Alignment (HIPAA, GxP, IRB)<a class="headerlink" href="#3-regulatory-compliance-alignment-hipaa-gxp-irb" title="Permanent link">&para;</a></h2>
<h3 id="31-regulatory-stack-referenced-in-internal-sources">3.1 Regulatory Stack Referenced in Internal Sources<a class="headerlink" href="#31-regulatory-stack-referenced-in-internal-sources" title="Permanent link">&para;</a></h3>
<ul>
<li>HIPAA Privacy Rule for PHI use and disclosure.</li>
<li>HIPAA Security Rule for administrative, physical, and technical safeguards.</li>
<li>HITECH Act for expanded breach notification requirements.</li>
<li>GxP compliance references in life sciences expert network data.</li>
<li>IRB oversight noted in clinical research platforms (Advarra).</li>
<li>Medical device compliance expectations in healthcare sector analysis.</li>
<li>HITRUST alignment mentioned as high-ROI in healthcare security research.</li>
<li>State privacy rules augment HIPAA obligations for health data.</li>
<li>Vendor contract obligations via BAAs and security clauses.</li>
</ul>
<h3 id="32-hipaa-update-signals-internal-2025-notes">3.2 HIPAA Update Signals (Internal 2025 Notes)<a class="headerlink" href="#32-hipaa-update-signals-internal-2025-notes" title="Permanent link">&para;</a></h3>
<ul>
<li>Zero Trust expectations integrated into HIPAA interpretations.</li>
<li>Universal MFA requirements for privileged access and critical systems.</li>
<li>30-day breach notification window for incident reporting.</li>
<li>Annual pentesting and twice-yearly vulnerability scans referenced.</li>
<li>Increased compliance spend estimates (internal estimate $4.6B/year).</li>
</ul>
<h3 id="33-fda-adjacent-compliance-signals-gxp-irb">3.3 FDA-Adjacent Compliance Signals (GxP / IRB)<a class="headerlink" href="#33-fda-adjacent-compliance-signals-gxp-irb" title="Permanent link">&para;</a></h3>
<ul>
<li>GxP compliance is explicitly referenced in expert network data (Advarra).</li>
<li>IRB oversight appears in clinical research platform descriptions.</li>
<li>Due diligence checklists include PCI/HIPAA/GxP evidence and audit results.</li>
<li>Life sciences platforms emphasize regulatory compliance for clinical research.</li>
<li>For pharma/biotech, treat GxP evidence as FDA-aligned compliance artifacts.</li>
<li>Maintain audit trails and evidence packages to support regulated audits.</li>
</ul>
<h3 id="34-compliance-evidence-expectations">3.4 Compliance Evidence Expectations<a class="headerlink" href="#34-compliance-evidence-expectations" title="Permanent link">&para;</a></h3>
<ul>
<li>SOC 2 or ISO 27001 reports where applicable.</li>
<li>PCI/HIPAA/GxP evidence and audit results as part of diligence.</li>
<li>Data classification policies and encryption standards.</li>
<li>Incident response plans and tabletop exercise summaries.</li>
<li>Vendor contracts with security clauses and audit rights.</li>
<li>Backup and recovery test evidence.</li>
<li>Regulatory correspondence or enforcement notices.</li>
</ul>
<h3 id="35-consultant-translation-layer">3.5 Consultant Translation Layer<a class="headerlink" href="#35-consultant-translation-layer" title="Permanent link">&para;</a></h3>
<ul>
<li>Map regulatory requirements into control objectives and audit-ready evidence.</li>
<li>Create a compliance roadmap with prioritized remediation milestones.</li>
<li>Align policies with operational controls and measurable outcomes.</li>
<li>Treat GxP compliance as a data integrity and traceability requirement.</li>
</ul>
<h2 id="4-data-inventory-classification-and-ip-protection">4. Data Inventory, Classification, and IP Protection<a class="headerlink" href="#4-data-inventory-classification-and-ip-protection" title="Permanent link">&para;</a></h2>
<h3 id="41-sensitive-data-types-in-pharmabiotech">4.1 Sensitive Data Types in Pharma/Biotech<a class="headerlink" href="#41-sensitive-data-types-in-pharmabiotech" title="Permanent link">&para;</a></h3>
<ul>
<li>PHI and ePHI in clinical trial and patient data sets.</li>
<li>Proprietary drug formulas, biologics, and lab methodologies.</li>
<li>Clinical trial protocols, endpoints, and interim results.</li>
<li>Research datasets and bioinformatics pipelines.</li>
<li>Manufacturing batch records and quality documentation.</li>
<li>Supplier specifications and logistics routing data.</li>
<li>Regulatory submissions and audit documentation.</li>
<li>IP portfolios, patents, and trade secret documentation.</li>
<li>Vendor contracts and licensing agreements.</li>
<li>Financial forecasts tied to product pipelines.</li>
</ul>
<h3 id="42-ip-protection-drivers-from-internal-research">4.2 IP Protection Drivers from Internal Research<a class="headerlink" href="#42-ip-protection-drivers-from-internal-research" title="Permanent link">&para;</a></h3>
<ul>
<li>Pharma/biotech premiums are linked to IP protection and R&amp;D security.</li>
<li>AI security research cites model theft and IP protection needs.</li>
<li>Privacy guidance flags trade secrets and IP constraints in disclosures.</li>
<li>Security architecture research emphasizes ownership of deliverables and IP.</li>
<li>Threat intelligence contracting guidance stresses IP rights for deliverables.</li>
<li>Expert network demand highlights biotech breakthroughs as a hot topic.</li>
</ul>
<h3 id="43-data-classification-and-handling-controls">4.3 Data Classification and Handling Controls<a class="headerlink" href="#43-data-classification-and-handling-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Define data tiers for PHI, R&amp;D IP, regulated evidence, and public data.</li>
<li>Assign encryption requirements by data tier and system location.</li>
<li>Enforce least privilege for lab systems and research platforms.</li>
<li>Maintain retention schedules aligned with regulatory obligations.</li>
<li>Implement data loss prevention controls for high-value IP.</li>
<li>Create secure collaboration zones for external research partners.</li>
<li>Log and monitor access to regulated evidence repositories.</li>
<li>Document cross-border data flows for global trial partners.</li>
<li>Limit dataset exports and enforce data minimization policies.</li>
<li>Establish secure disposal procedures for lab devices and media.</li>
</ul>
<h3 id="44-ip-protection-engagement-deliverables">4.4 IP Protection Engagement Deliverables<a class="headerlink" href="#44-ip-protection-engagement-deliverables" title="Permanent link">&para;</a></h3>
<ul>
<li>IP risk assessment and threat model for core R&amp;D assets.</li>
<li>Trade secret inventory aligned to data classification tiers.</li>
<li>Secure lab notebook and evidence trail design.</li>
<li>Access control reviews for source code, formulas, and models.</li>
<li>Vendor contract clauses covering IP confidentiality and security.</li>
<li>Incident response playbooks for IP theft scenarios.</li>
<li>Metrics dashboard for IP access and anomaly detection.</li>
</ul>
<h2 id="5-governance-grc-program-design">5. Governance &amp; GRC Program Design<a class="headerlink" href="#5-governance-grc-program-design" title="Permanent link">&para;</a></h2>
<h3 id="51-governance-structure">5.1 Governance Structure<a class="headerlink" href="#51-governance-structure" title="Permanent link">&para;</a></h3>
<ul>
<li>Define security ownership for R&amp;D, clinical, manufacturing, and IT domains.</li>
<li>Establish a security steering committee with compliance participation.</li>
<li>Implement risk registers aligned to regulatory and business impact.</li>
<li>Define board-level reporting cadence for top risks and incidents.</li>
<li>Align policies to HIPAA and GxP obligations with evidence mapping.</li>
<li>Maintain a compliance calendar for audits and assessments.</li>
<li>Use standardized templates for policy updates and attestation.</li>
</ul>
<h3 id="52-core-grc-controls">5.2 Core GRC Controls<a class="headerlink" href="#52-core-grc-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Risk analysis and risk management process.</li>
<li>Security management process and assigned responsibilities.</li>
<li>Workforce onboarding/offboarding controls.</li>
<li>Security awareness and training requirements.</li>
<li>Information access management and role definitions.</li>
<li>Incident response planning and documentation.</li>
<li>Facility access controls and visitor procedures.</li>
<li>Device and media controls for lab and plant equipment.</li>
<li>Audit controls and log review processes.</li>
<li>Integrity controls for regulated data systems.</li>
</ul>
<h3 id="53-evidence-management">5.3 Evidence Management<a class="headerlink" href="#53-evidence-management" title="Permanent link">&para;</a></h3>
<ul>
<li>Maintain an "auditor binder" with organized evidence artifacts.</li>
<li>Provide control mappings for HIPAA and GxP requirements.</li>
<li>Track remediation progress with owner and due date fields.</li>
<li>Store evidence in access-controlled repositories.</li>
<li>Maintain version control for policies and SOPs.</li>
<li>Collect records of vulnerability scans and pentest reports.</li>
<li>Document vendor assessments and security questionnaires.</li>
<li>Archive incident response exercises and lessons learned.</li>
</ul>
<h2 id="6-research-lab-and-clinical-trial-security">6. Research, Lab, and Clinical Trial Security<a class="headerlink" href="#6-research-lab-and-clinical-trial-security" title="Permanent link">&para;</a></h2>
<h3 id="61-lab-and-research-security-controls">6.1 Lab and Research Security Controls<a class="headerlink" href="#61-lab-and-research-security-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Enforce MFA for lab systems and research platforms.</li>
<li>Segment lab networks from corporate IT and guest networks.</li>
<li>Maintain asset inventories for lab equipment and IoT devices.</li>
<li>Limit admin access to lab instruments and shared systems.</li>
<li>Encrypt research datasets at rest and in transit.</li>
<li>Implement secure remote access for researchers and vendors.</li>
<li>Monitor data exports to external research partners.</li>
<li>Implement secure collaboration workflows for multi-site studies.</li>
<li>Validate patching procedures for lab systems with operational safety.</li>
<li>Establish SOPs for handling biosafety and data security.</li>
</ul>
<h3 id="62-clinical-trial-data-integrity">6.2 Clinical Trial Data Integrity<a class="headerlink" href="#62-clinical-trial-data-integrity" title="Permanent link">&para;</a></h3>
<ul>
<li>Secure trial databases and electronic data capture (EDC) systems.</li>
<li>Implement access logs for trial data modifications.</li>
<li>Ensure audit logs are tamper-evident and retained.</li>
<li>Validate data integrity controls for trial endpoints.</li>
<li>Monitor for anomalous data access in trial systems.</li>
<li>Protect trial participant privacy and PHI data.</li>
<li>Use encryption for data transfers to CROs and regulators.</li>
<li>Maintain chain-of-custody for trial data extracts.</li>
<li>Ensure vendor contracts address trial data security responsibilities.</li>
<li>Conduct tabletop exercises for trial data breaches.</li>
</ul>
<h3 id="63-clinical-research-ecosystem-management">6.3 Clinical Research Ecosystem Management<a class="headerlink" href="#63-clinical-research-ecosystem-management" title="Permanent link">&para;</a></h3>
<ul>
<li>Assess CRO security posture and compliance evidence.</li>
<li>Require IRB-related security documentation for research partners.</li>
<li>Validate GxP compliance for data handling processes.</li>
<li>Implement secure data-sharing agreements with research collaborators.</li>
<li>Conduct periodic audits of trial vendors and cloud services.</li>
<li>Ensure least privilege access for external study monitors.</li>
<li>Review third-party data processors for cross-border compliance.</li>
</ul>
<h2 id="7-manufacturing-otics-security-for-pharma-plants">7. Manufacturing &amp; OT/ICS Security for Pharma Plants<a class="headerlink" href="#7-manufacturing-otics-security-for-pharma-plants" title="Permanent link">&para;</a></h2>
<h3 id="71-otics-context-for-pharma">7.1 OT/ICS Context for Pharma<a class="headerlink" href="#71-otics-context-for-pharma" title="Permanent link">&para;</a></h3>
<ul>
<li>Pharma manufacturing is part of OT/ICS security scope.</li>
<li>OT security requires safety-first controls and change management.</li>
<li>Asset visibility is the first phase for plant security programs.</li>
<li>Segmentation between IT and OT reduces lateral movement risks.</li>
<li>Vendor remote access must be tightly controlled and monitored.</li>
</ul>
<h3 id="72-otics-security-controls">7.2 OT/ICS Security Controls<a class="headerlink" href="#72-otics-security-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Build a comprehensive asset inventory of PLCs, HMIs, DCS, and historians.</li>
<li>Implement passive network monitoring for OT visibility.</li>
<li>Create OT network segmentation and IDMZ architecture.</li>
<li>Establish vendor remote access policies and SOPs.</li>
<li>Integrate OT alerting into enterprise SOC workflows.</li>
<li>Implement backup and recovery plans for OT systems.</li>
<li>Define patching windows aligned with production schedules.</li>
<li>Require MFA for remote engineering access where possible.</li>
<li>Maintain safety and availability as top priorities.</li>
<li>Use safety-focused risk assessments for control changes.</li>
</ul>
<h3 id="73-pharma-manufacturing-positioning">7.3 Pharma Manufacturing Positioning<a class="headerlink" href="#73-pharma-manufacturing-positioning" title="Permanent link">&para;</a></h3>
<ul>
<li>Niche down: "OT Security Architect for Pharma Manufacturing" positioning.</li>
<li>Offer phased engagements: visibility, segmentation, detection, response.</li>
<li>Align OT work with plant managers and safety leadership.</li>
<li>Use vendor partnerships (Claroty/Nozomi/Dragos) where applicable.</li>
<li>Document safety impact assessments for each control change.</li>
</ul>
<h2 id="8-supply-chain-logistics-security-for-high-value-shipments">8. Supply Chain &amp; Logistics Security for High-Value Shipments<a class="headerlink" href="#8-supply-chain-logistics-security-for-high-value-shipments" title="Permanent link">&para;</a></h2>
<h3 id="81-supply-chain-threat-signals">8.1 Supply Chain Threat Signals<a class="headerlink" href="#81-supply-chain-threat-signals" title="Permanent link">&para;</a></h3>
<ul>
<li>Cargo theft of high-value goods (electronics, pharma) rose 40% YoY.</li>
<li>Supply chain disruptions impact trial timelines and product availability.</li>
<li>Third-party vendors are a common breach vector in security incidents.</li>
<li>Regulatory supply chain laws and compliance requirements are rising.</li>
</ul>
<h3 id="82-supply-chain-security-controls">8.2 Supply Chain Security Controls<a class="headerlink" href="#82-supply-chain-security-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Secure high-value shipment routing and tracking workflows.</li>
<li>Implement tamper-evident packaging and secure handoff procedures.</li>
<li>Enforce access controls in distribution and warehouse environments.</li>
<li>Monitor logistics platforms for unauthorized access.</li>
<li>Apply C-SCRM practices to software and vendor dependencies.</li>
<li>Validate cold-chain monitoring devices and data integrity.</li>
<li>Conduct vendor risk assessments for logistics partners.</li>
<li>Ensure incident response plans include logistics stakeholders.</li>
<li>Track chain-of-custody for high-value shipments.</li>
</ul>
<h3 id="83-consulting-opportunities">8.3 Consulting Opportunities<a class="headerlink" href="#83-consulting-opportunities" title="Permanent link">&para;</a></h3>
<ul>
<li>Supply chain security assessments for pharma distribution networks.</li>
<li>Vendor risk audits for logistics providers and CMOs.</li>
<li>Incident response playbooks for cargo theft or diversion.</li>
<li>Integration of cyber and physical security controls for shipments.</li>
</ul>
<h2 id="9-cloud-api-and-application-security-in-life-sciences">9. Cloud, API, and Application Security in Life Sciences<a class="headerlink" href="#9-cloud-api-and-application-security-in-life-sciences" title="Permanent link">&para;</a></h2>
<h3 id="91-cloud-security-in-rd">9.1 Cloud Security in R&amp;D<a class="headerlink" href="#91-cloud-security-in-rd" title="Permanent link">&para;</a></h3>
<ul>
<li>Cloud security assessments for research and analytics platforms.</li>
<li>Encryption strategy for cloud storage of research datasets.</li>
<li>Access control reviews for data lakes and analytics tools.</li>
<li>Logging and monitoring for cloud environments with sensitive data.</li>
<li>Secure collaboration across multiple research partners.</li>
</ul>
<h3 id="92-api-security-and-industry-premiums">9.2 API Security and Industry Premiums<a class="headerlink" href="#92-api-security-and-industry-premiums" title="Permanent link">&para;</a></h3>
<ul>
<li>Small API footprint: $6K–$15K for fixed-fee assessments.</li>
<li>Medium API footprint: $15K–$40K for fixed-fee assessments.</li>
<li>Large API footprint: $40K–$120K+ for multi-service scopes.</li>
<li>Healthcare/life sciences API security premium: +10–30%.</li>
<li>Premium factors include multi-tenant separation and high-risk auth flows.</li>
</ul>
<h3 id="93-application-security-controls">9.3 Application Security Controls<a class="headerlink" href="#93-application-security-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Secure SDLC and code review practices for clinical software.</li>
<li>Threat modeling for patient portals and trial management apps.</li>
<li>Authentication hardening with MFA and least privilege.</li>
<li>Secure configuration management for SaaS tools.</li>
<li>Continuous vulnerability scanning and remediation tracking.</li>
<li>Penetration testing aligned to compliance expectations.</li>
<li>Secure logging and audit trails for regulated applications.</li>
</ul>
<h2 id="10-incident-response-ransomware-resilience">10. Incident Response &amp; Ransomware Resilience<a class="headerlink" href="#10-incident-response-ransomware-resilience" title="Permanent link">&para;</a></h2>
<h3 id="101-incident-response-foundations">10.1 Incident Response Foundations<a class="headerlink" href="#101-incident-response-foundations" title="Permanent link">&para;</a></h3>
<ul>
<li>Maintain incident response plans with defined roles and escalation.</li>
<li>Conduct tabletop exercises at least annually.</li>
<li>Keep a 24–36 month incident history for reporting and audits.</li>
<li>Define breach notification workflows to meet 30-day timelines.</li>
<li>Integrate IR with legal and compliance stakeholders.</li>
</ul>
<h3 id="102-ransomware-resilience">10.2 Ransomware Resilience<a class="headerlink" href="#102-ransomware-resilience" title="Permanent link">&para;</a></h3>
<ul>
<li>Implement immutable backups and regular recovery testing.</li>
<li>Segment networks to prevent ransomware spread.</li>
<li>Harden endpoint detection and response (EDR) coverage.</li>
<li>Validate incident response playbooks for clinical and manufacturing systems.</li>
<li>Establish criteria for production shutdown or isolation.</li>
</ul>
<h3 id="103-consulting-service-opportunities">10.3 Consulting Service Opportunities<a class="headerlink" href="#103-consulting-service-opportunities" title="Permanent link">&para;</a></h3>
<ul>
<li>Ransomware resilience audit (~$7.5K internal benchmark).</li>
<li>Incident response tabletop exercises ($5K–$8K benchmark).</li>
<li>On-call IR retainers for rapid response readiness.</li>
<li>Post-incident remediation and recovery support.</li>
</ul>
<h2 id="11-third-party-risk-management-vendor-governance">11. Third-Party Risk Management &amp; Vendor Governance<a class="headerlink" href="#11-third-party-risk-management-vendor-governance" title="Permanent link">&para;</a></h2>
<h3 id="111-vendor-risk-drivers">11.1 Vendor Risk Drivers<a class="headerlink" href="#111-vendor-risk-drivers" title="Permanent link">&para;</a></h3>
<ul>
<li>BAAs and vendor security clauses create shared liability.</li>
<li>Vendor breaches can trigger HIPAA and compliance penalties.</li>
<li>CROs and CMOs introduce extensive data handling risks.</li>
<li>Clinical SaaS vendors store high volumes of sensitive data.</li>
</ul>
<h3 id="112-vendor-risk-program-controls">11.2 Vendor Risk Program Controls<a class="headerlink" href="#112-vendor-risk-program-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Maintain a critical vendor inventory with risk tiers.</li>
<li>Require SOC reports, security questionnaires, or ISO evidence.</li>
<li>Validate GxP compliance for regulated vendors.</li>
<li>Enforce contract clauses for breach notification timelines.</li>
<li>Track vendor remediation and risk acceptance decisions.</li>
<li>Perform periodic vendor audits or onsite reviews where required.</li>
<li>Monitor vendor access and least privilege controls.</li>
<li>Include termination and data return clauses in contracts.</li>
</ul>
<h3 id="113-vendor-audit-offerings">11.3 Vendor Audit Offerings<a class="headerlink" href="#113-vendor-audit-offerings" title="Permanent link">&para;</a></h3>
<ul>
<li>Vendor security audit packages ($1.5K–$3K per vendor, internal healthcare benchmarks).</li>
<li>Third-party risk scoring and remediation roadmaps.</li>
<li>Continuous monitoring services for high-risk vendors.</li>
<li>Specialized reviews for clinical trial and lab vendors.</li>
</ul>
<h2 id="12-ma-and-due-diligence-in-pharmabiotech">12. M&amp;A and Due Diligence in Pharma/Biotech<a class="headerlink" href="#12-ma-and-due-diligence-in-pharmabiotech" title="Permanent link">&para;</a></h2>
<h3 id="121-diligence-pricing-signals">12.1 Diligence Pricing Signals<a class="headerlink" href="#121-diligence-pricing-signals" title="Permanent link">&para;</a></h3>
<ul>
<li>Diligence under $50M EV: $15K–$60K (Tier 0–1).</li>
<li>$50M–$250M EV: $40K–$150K (Tier 1).</li>
<li>$250M–$1B EV: $150K–$400K (Tier 1–2).</li>
<li>$1B+ EV: $400K–$1.5M+ depending on scope.</li>
<li>Healthcare/life sciences add 20–70% for PHI and compliance checks.</li>
</ul>
<h3 id="122-diligence-evidence-checklist">12.2 Diligence Evidence Checklist<a class="headerlink" href="#122-diligence-evidence-checklist" title="Permanent link">&para;</a></h3>
<ul>
<li>SOC 2 or ISO 27001 reports.</li>
<li>PCI/HIPAA/GxP evidence and audit results.</li>
<li>Data classification and encryption standards.</li>
<li>Incident history and response evidence.</li>
<li>Backup and recovery test documentation.</li>
<li>Vendor contracts with security clauses.</li>
<li>Regulatory correspondence and enforcement notices.</li>
</ul>
<h3 id="123-post-close-integration-focus">12.3 Post-Close Integration Focus<a class="headerlink" href="#123-post-close-integration-focus" title="Permanent link">&para;</a></h3>
<ul>
<li>Align identity and access controls across entities.</li>
<li>Consolidate logging, monitoring, and EDR tooling.</li>
<li>Harmonize data classification and retention policies.</li>
<li>Update incident response plans for the combined entity.</li>
<li>Validate compliance requirements for merged data flows.</li>
</ul>
<h2 id="13-engagement-models-deliverable-packages">13. Engagement Models &amp; Deliverable Packages<a class="headerlink" href="#13-engagement-models-deliverable-packages" title="Permanent link">&para;</a></h2>
<h3 id="131-common-engagement-structures">13.1 Common Engagement Structures<a class="headerlink" href="#131-common-engagement-structures" title="Permanent link">&para;</a></h3>
<ul>
<li>Fixed-fee readiness assessments for compliance gaps.</li>
<li>vCISO retainers for ongoing governance and reporting.</li>
<li>Technical sprints for API security, pentests, or segmentation.</li>
<li>Managed security or MDR partnerships for continuous monitoring.</li>
<li>Expert witness support for litigation and compliance disputes.</li>
</ul>
<h3 id="132-healthcare-benchmark-packages-adaptable-to-life-sciences">13.2 Healthcare Benchmark Packages (Adaptable to Life Sciences)<a class="headerlink" href="#132-healthcare-benchmark-packages-adaptable-to-life-sciences" title="Permanent link">&para;</a></h3>
<ul>
<li>HIPAA readiness assessment: $3K–$5K small practices.</li>
<li>Mid-sized clinic readiness: $8K–$15K.</li>
<li>Regional hospital readiness: $25K–$60K+.</li>
<li>vCISO retainer Tier 1: $2.5K–$4K/mo.</li>
<li>vCISO retainer Tier 2: $5K–$8K/mo.</li>
<li>vCISO retainer Tier 3: $10K–$20K+/mo.</li>
<li>Medical device inventory audit: $10K+.</li>
<li>Incident response tabletop: $5K–$8K.</li>
<li>Ransomware resilience audit: ~$7.5K.</li>
</ul>
<h3 id="133-standard-deliverables">13.3 Standard Deliverables<a class="headerlink" href="#133-standard-deliverables" title="Permanent link">&para;</a></h3>
<ul>
<li>Current-state security assessment and gap analysis.</li>
<li>Control mapping for HIPAA and GxP requirements.</li>
<li>Data flow diagrams for PHI and research data.</li>
<li>Risk register with remediation priorities.</li>
<li>Compliance roadmap with milestones.</li>
<li>Security policy updates and SOPs.</li>
<li>Incident response playbooks and communication templates.</li>
<li>Vendor risk assessment reports.</li>
<li>Executive summary for board or investors.</li>
</ul>
<h2 id="14-rate-pricing-benchmarks">14. Rate &amp; Pricing Benchmarks<a class="headerlink" href="#14-rate-pricing-benchmarks" title="Permanent link">&para;</a></h2>
<h3 id="141-hourly-rate-benchmarks-healthcare-baseline">14.1 Hourly Rate Benchmarks (Healthcare Baseline)<a class="headerlink" href="#141-hourly-rate-benchmarks-healthcare-baseline" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Role / Specialization</th>
<th>Junior</th>
<th>Mid-Level</th>
<th>Senior/Principal</th>
</tr>
</thead>
<tbody>
<tr>
<td>General Healthcare Security Analyst</td>
<td>$60–$90</td>
<td>$90–$150</td>
<td>$150–$225</td>
</tr>
<tr>
<td>HIPAA Compliance Consultant</td>
<td>$50–$85</td>
<td>$85–$135</td>
<td>$135–$200</td>
</tr>
<tr>
<td>Virtual CISO (vCISO)</td>
<td>N/A</td>
<td>$200–$300</td>
<td>$300–$500+</td>
</tr>
<tr>
<td>Healthcare Pen Tester</td>
<td>$100–$150</td>
<td>$150–$250</td>
<td>$250–$400</td>
</tr>
<tr>
<td>DFIR</td>
<td>$175–$225</td>
<td>$225–$350</td>
<td>$400–$650+</td>
</tr>
<tr>
<td>Expert Witness</td>
<td>N/A</td>
<td>$250–$400</td>
<td>$450–$800+</td>
</tr>
</tbody>
</table>
<h3 id="142-industry-premium-signals">14.2 Industry Premium Signals<a class="headerlink" href="#142-industry-premium-signals" title="Permanent link">&para;</a></h3>
<ul>
<li>Pharma/biotech median pay: $203,846 (PayScale and security salary research).</li>
<li>Pharma/biotech premium: +26% to +50% above baseline due to IP and compliance.</li>
<li>Healthcare premium: +10% to +25% for PHI and medical device risk.</li>
<li>API security premium for healthcare/life sciences: +10–30%.</li>
<li>M&amp;A diligence premium for healthcare/life sciences: +20–70%.</li>
<li>OT/ICS work commands premium rates due to scarce talent and operational risk.</li>
</ul>
<h3 id="143-expert-network-rate-signals-life-sciences">14.3 Expert Network Rate Signals (Life Sciences)<a class="headerlink" href="#143-expert-network-rate-signals-life-sciences" title="Permanent link">&para;</a></h3>
<ul>
<li>Physicians: $500–$1,000+/hour.</li>
<li>Nurses: $150–$300/hour.</li>
<li>Pharmacists: $200–$400/hour.</li>
<li>Clinical researchers: $250–$500/hour.</li>
<li>Healthcare administrators: $150–$300/hour.</li>
<li>Veterinarians: $200–$400/hour.</li>
<li>Lab technicians: $100–$250/hour.</li>
<li>Senior experts: $400–$500/hour typical, $500–$1,500+ premium.</li>
</ul>
<h3 id="144-specialist-network-benchmarks">14.4 Specialist Network Benchmarks<a class="headerlink" href="#144-specialist-network-benchmarks" title="Permanent link">&para;</a></h3>
<ul>
<li>Techspert reported rate: 200€/hour (~$220 USD).</li>
<li>Techspert payments: within 10 days (internal network research).</li>
<li>Expert networks often support $300–$1,000/hr consultations for healthcare topics.</li>
<li>Pharma/biotech SMEs are scarce and can command premium rates.</li>
</ul>
<h2 id="15-expert-networks-sme-sourcing">15. Expert Networks &amp; SME Sourcing<a class="headerlink" href="#15-expert-networks-sme-sourcing" title="Permanent link">&para;</a></h2>
<h3 id="151-life-sciences-focused-networks">15.1 Life Sciences-Focused Networks<a class="headerlink" href="#151-life-sciences-focused-networks" title="Permanent link">&para;</a></h3>
<ul>
<li>Techspert: healthcare/life sciences specialist network (AI matching).</li>
<li>Alacrita: 350+ life sciences experts (Reddit research).</li>
<li>GLG Healthcare division and Third Bridge Healthcare.</li>
<li>Specialized networks for medical device, pharma, biotech professionals.</li>
</ul>
<h3 id="152-platforms-to-avoid-for-cybersecurity-focus">15.2 Platforms to Avoid for Cybersecurity Focus<a class="headerlink" href="#152-platforms-to-avoid-for-cybersecurity-focus" title="Permanent link">&para;</a></h3>
<ul>
<li>Advarra: clinical research, IRB, GxP compliance focus; no cybersecurity.</li>
<li>ClearView Healthcare Partners: life sciences only; not cybersecurity.</li>
<li>Techspert.io: healthcare/life sciences only; not cybersecurity focus.</li>
<li>proSapient and Third Bridge: invite-only with limited access.</li>
<li>Precision Sample/TestSet: market research surveys only.</li>
</ul>
<h3 id="153-platform-insight-highlights">15.3 Platform Insight Highlights<a class="headerlink" href="#153-platform-insight-highlights" title="Permanent link">&para;</a></h3>
<ul>
<li>NewtonX industries include life sciences alongside technology.</li>
<li>Tegus industries include life sciences in expert network scope.</li>
<li>Expert network guidance emphasizes niche expertise (biotech) to command premiums.</li>
<li>Expert network research lists biotech as a high-value niche specialization.</li>
<li>SME sourcing is critical for regulatory and clinical trial projects.</li>
</ul>
<h2 id="16-positioning-messaging-and-go-to-market">16. Positioning, Messaging, and Go-To-Market<a class="headerlink" href="#16-positioning-messaging-and-go-to-market" title="Permanent link">&para;</a></h2>
<h3 id="161-positioning-angles">16.1 Positioning Angles<a class="headerlink" href="#161-positioning-angles" title="Permanent link">&para;</a></h3>
<ul>
<li>"R&amp;D Security for Drug Discovery and Clinical Trials."</li>
<li>"GxP-Ready Security for Life Sciences Data Platforms."</li>
<li>"OT Security Architect for Pharma Manufacturing."</li>
<li>"IP Protection and Trade Secret Defense for Biotech."</li>
<li>"Clinical Trial Data Integrity and Compliance."</li>
<li>"M&amp;A Security Diligence for Biotech Investors."</li>
</ul>
<h3 id="162-messaging-themes">16.2 Messaging Themes<a class="headerlink" href="#162-messaging-themes" title="Permanent link">&para;</a></h3>
<ul>
<li>Emphasize IP protection as revenue protection.</li>
<li>Frame compliance as resilience and audit readiness.</li>
<li>Highlight breach cost ROI using $9.77M–$10.93M benchmarks.</li>
<li>Align security scope to patient safety and product quality.</li>
<li>Stress vendor accountability and supply chain risk containment.</li>
</ul>
<h3 id="163-sales-channels">16.3 Sales Channels<a class="headerlink" href="#163-sales-channels" title="Permanent link">&para;</a></h3>
<ul>
<li>LinkedIn outreach to compliance officers and R&amp;D leadership.</li>
<li>Expert networks for paid consultations with investors.</li>
<li>Partnerships with CROs, CMOs, and healthcare MSPs.</li>
<li>Speaking engagements at healthcare or biotech associations.</li>
</ul>
<h2 id="17-metrics-kpis-and-evidence-tracking">17. Metrics, KPIs, and Evidence Tracking<a class="headerlink" href="#17-metrics-kpis-and-evidence-tracking" title="Permanent link">&para;</a></h2>
<h3 id="171-compliance-and-security-kpis">17.1 Compliance and Security KPIs<a class="headerlink" href="#171-compliance-and-security-kpis" title="Permanent link">&para;</a></h3>
<ul>
<li>Percentage of systems with MFA enabled.</li>
<li>Patch compliance for lab and manufacturing assets.</li>
<li>Number of critical vulnerabilities remediated.</li>
<li>Mean time to detect and respond to incidents.</li>
<li>Coverage percentage for asset inventory (IT and OT).</li>
<li>Vendor assessment completion rate.</li>
<li>Incident response exercise frequency.</li>
</ul>
<h3 id="172-evidence-tracking-practices">17.2 Evidence Tracking Practices<a class="headerlink" href="#172-evidence-tracking-practices" title="Permanent link">&para;</a></h3>
<ul>
<li>Maintain an evidence register with timestamps.</li>
<li>Track audit artifacts by control requirement.</li>
<li>Store vulnerability scan reports and remediation proofs.</li>
<li>Record training completion and policy attestation.</li>
<li>Maintain incident records for 24–36 months.</li>
<li>Track backup recovery test success rates.</li>
</ul>
<h2 id="18-306090-day-execution-plan">18. 30/60/90-Day Execution Plan<a class="headerlink" href="#18-306090-day-execution-plan" title="Permanent link">&para;</a></h2>
<h3 id="181-first-30-days">18.1 First 30 Days<a class="headerlink" href="#181-first-30-days" title="Permanent link">&para;</a></h3>
<ul>
<li>Conduct discovery workshops with R&amp;D, IT, and compliance teams.</li>
<li>Build an asset inventory for lab, clinical, and manufacturing systems.</li>
<li>Collect existing policies, SOPs, and audit artifacts.</li>
<li>Identify critical data flows (PHI, R&amp;D IP, trial data).</li>
<li>Establish a risk register and prioritize top risks.</li>
</ul>
<h3 id="182-days-3160">18.2 Days 31–60<a class="headerlink" href="#182-days-3160" title="Permanent link">&para;</a></h3>
<ul>
<li>Deliver HIPAA/GxP gap analysis and compliance roadmap.</li>
<li>Implement MFA and access controls for critical systems.</li>
<li>Segment lab and manufacturing networks where feasible.</li>
<li>Launch vendor risk assessments for high-risk partners.</li>
<li>Prepare incident response playbooks and escalation paths.</li>
</ul>
<h3 id="183-days-6190">18.3 Days 61–90<a class="headerlink" href="#183-days-6190" title="Permanent link">&para;</a></h3>
<ul>
<li>Complete vulnerability scans and remediation plans.</li>
<li>Conduct tabletop exercises for ransomware and data breaches.</li>
<li>Deliver board-level reporting and risk updates.</li>
<li>Implement data loss prevention for IP and sensitive data.</li>
<li>Finalize audit-ready evidence binder.</li>
</ul>
<h2 id="19-appendix-a-pharmabiotech-control-checklist">19. Appendix A: Pharma/Biotech Control Checklist<a class="headerlink" href="#19-appendix-a-pharmabiotech-control-checklist" title="Permanent link">&para;</a></h2>
<h3 id="191-governance-policy-controls">19.1 Governance &amp; Policy Controls<a class="headerlink" href="#191-governance-policy-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Define security governance roles and responsibilities.</li>
<li>Establish a compliance steering committee.</li>
<li>Create a formal risk management process.</li>
<li>Maintain a regulatory compliance calendar.</li>
<li>Publish data classification and handling policies.</li>
<li>Define acceptable use policies for lab and research systems.</li>
<li>Document incident response roles and escalation paths.</li>
<li>Maintain change management procedures for critical systems.</li>
<li>Establish third-party risk management policies.</li>
<li>Document retention and destruction policies for regulated data.</li>
</ul>
<h3 id="192-identity-access-management">19.2 Identity &amp; Access Management<a class="headerlink" href="#192-identity-access-management" title="Permanent link">&para;</a></h3>
<ul>
<li>Enforce MFA for privileged and clinical accounts.</li>
<li>Implement least privilege access for research data.</li>
<li>Remove shared accounts from lab systems where possible.</li>
<li>Review access rights quarterly for critical platforms.</li>
<li>Integrate centralized identity management for cloud apps.</li>
<li>Require strong authentication for vendor remote access.</li>
<li>Monitor failed authentication attempts and anomalies.</li>
<li>Implement role-based access controls for trial systems.</li>
<li>Maintain logs of access changes and approvals.</li>
<li>Use just-in-time access for administrative tasks.</li>
</ul>
<h3 id="193-data-protection-ip-controls">19.3 Data Protection &amp; IP Controls<a class="headerlink" href="#193-data-protection-ip-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Encrypt PHI and regulated data at rest.</li>
<li>Encrypt data in transit for inter-partner transfers.</li>
<li>Apply DLP controls to R&amp;D repositories.</li>
<li>Use secure collaboration platforms for external partners.</li>
<li>Implement data masking for non-production environments.</li>
<li>Limit data exports and enforce approval workflows.</li>
<li>Maintain secure key management and rotation procedures.</li>
<li>Store trade secret documentation in access-controlled vaults.</li>
<li>Monitor for unusual data exfiltration patterns.</li>
<li>Define IP access policies for contractors and vendors.</li>
</ul>
<h3 id="194-network-segmentation">19.4 Network &amp; Segmentation<a class="headerlink" href="#194-network-segmentation" title="Permanent link">&para;</a></h3>
<ul>
<li>Segment lab networks from corporate IT.</li>
<li>Create an OT/IT DMZ for manufacturing systems.</li>
<li>Restrict outbound internet access for lab instruments.</li>
<li>Monitor network traffic for anomalous flows.</li>
<li>Implement firewall policies aligned to data sensitivity.</li>
<li>Maintain secure VPN configurations for remote access.</li>
<li>Disable unused network services on critical systems.</li>
<li>Validate segmentation rules quarterly.</li>
<li>Deploy network monitoring in OT environments.</li>
<li>Use micro-segmentation where feasible for high-risk assets.</li>
</ul>
<h3 id="195-endpoint-device-security">19.5 Endpoint &amp; Device Security<a class="headerlink" href="#195-endpoint-device-security" title="Permanent link">&para;</a></h3>
<ul>
<li>Deploy EDR across workstations and servers.</li>
<li>Maintain antivirus coverage for lab and clinical systems.</li>
<li>Apply patch management procedures for supported devices.</li>
<li>Track asset inventory for lab equipment and IoMT.</li>
<li>Secure portable media usage with encryption.</li>
<li>Enforce device hardening standards.</li>
<li>Disable USB storage on sensitive systems.</li>
<li>Monitor endpoint health and compliance status.</li>
<li>Implement secure configuration baselines.</li>
<li>Document exceptions for legacy devices.</li>
</ul>
<h3 id="196-application-api-security">19.6 Application &amp; API Security<a class="headerlink" href="#196-application-api-security" title="Permanent link">&para;</a></h3>
<ul>
<li>Perform secure code reviews for clinical applications.</li>
<li>Maintain vulnerability scanning for web apps and APIs.</li>
<li>Conduct regular penetration tests for high-risk apps.</li>
<li>Enforce secure authentication and session management.</li>
<li>Use API gateway policies with rate limiting and logging.</li>
<li>Validate input/output for data integrity.</li>
<li>Implement secure secrets management in CI/CD pipelines.</li>
<li>Maintain audit logs for critical application actions.</li>
<li>Test for data leakage in API responses.</li>
<li>Apply least privilege to service accounts.</li>
</ul>
<h3 id="197-otics-security-controls">19.7 OT/ICS Security Controls<a class="headerlink" href="#197-otics-security-controls" title="Permanent link">&para;</a></h3>
<ul>
<li>Maintain OT asset inventory and network diagrams.</li>
<li>Deploy passive monitoring for OT environments.</li>
<li>Restrict vendor remote access to controlled windows.</li>
<li>Implement role-based access for engineers.</li>
<li>Maintain backup images of PLC configurations.</li>
<li>Document emergency procedures for OT incidents.</li>
<li>Align patching to production schedules.</li>
<li>Integrate OT alerts into SOC workflows.</li>
<li>Establish OT incident response playbooks.</li>
<li>Validate safety impact before security changes.</li>
</ul>
<h3 id="198-clinical-trial-security">19.8 Clinical Trial Security<a class="headerlink" href="#198-clinical-trial-security" title="Permanent link">&para;</a></h3>
<ul>
<li>Encrypt clinical trial data at rest and in transit.</li>
<li>Maintain audit logs for trial data modifications.</li>
<li>Validate EDC system access controls.</li>
<li>Track trial data exports and approvals.</li>
<li>Implement secure data sharing with CROs.</li>
<li>Enforce participant privacy protections.</li>
<li>Conduct trial data breach tabletop exercises.</li>
<li>Maintain chain-of-custody documentation.</li>
<li>Validate data integrity checksums where possible.</li>
<li>Document IRB-related security approvals.</li>
</ul>
<h3 id="199-vendor-third-party-risk">19.9 Vendor &amp; Third-Party Risk<a class="headerlink" href="#199-vendor-third-party-risk" title="Permanent link">&para;</a></h3>
<ul>
<li>Maintain a list of critical vendors and data processors.</li>
<li>Require SOC reports or equivalent evidence.</li>
<li>Validate GxP compliance for clinical vendors.</li>
<li>Include breach notification clauses in contracts.</li>
<li>Enforce right-to-audit language in agreements.</li>
<li>Track vendor remediation actions and deadlines.</li>
<li>Monitor vendor access logs for anomalies.</li>
<li>Review vendor access quarterly.</li>
<li>Require secure onboarding/offboarding for vendor accounts.</li>
<li>Maintain vendor risk scoring and reporting.</li>
</ul>
<h3 id="1910-incident-response-resilience">19.10 Incident Response &amp; Resilience<a class="headerlink" href="#1910-incident-response-resilience" title="Permanent link">&para;</a></h3>
<ul>
<li>Maintain an incident response plan with contact lists.</li>
<li>Conduct annual tabletop exercises.</li>
<li>Define ransomware-specific response workflows.</li>
<li>Implement immutable backup strategies.</li>
<li>Test recovery procedures quarterly.</li>
<li>Maintain forensic readiness procedures.</li>
<li>Establish communication templates for regulators and clients.</li>
<li>Document incident handling timelines and actions.</li>
<li>Track breach notification deadlines.</li>
<li>Maintain a post-incident lessons-learned process.</li>
</ul>
<h3 id="1911-physical-facility-security">19.11 Physical &amp; Facility Security<a class="headerlink" href="#1911-physical-facility-security" title="Permanent link">&para;</a></h3>
<ul>
<li>Enforce visitor management for labs and plants.</li>
<li>Require badge access for secure areas.</li>
<li>Implement camera surveillance for critical facilities.</li>
<li>Secure storage for lab notebooks and devices.</li>
<li>Protect data centers and server rooms with access controls.</li>
<li>Maintain environmental monitoring for sensitive storage.</li>
<li>Document physical security incident response.</li>
<li>Secure offsite storage for backup media.</li>
<li>Validate shipping and receiving controls.</li>
<li>Apply asset tagging for critical equipment.</li>
</ul>
<h3 id="1912-training-awareness">19.12 Training &amp; Awareness<a class="headerlink" href="#1912-training-awareness" title="Permanent link">&para;</a></h3>
<ul>
<li>Provide HIPAA and GxP security training annually.</li>
<li>Train staff on phishing and social engineering risks.</li>
<li>Conduct role-specific training for lab personnel.</li>
<li>Provide incident reporting training.</li>
<li>Maintain training completion records for audits.</li>
<li>Offer secure data handling training for researchers.</li>
<li>Train manufacturing staff on OT security basics.</li>
<li>Provide vendor security onboarding materials.</li>
<li>Run simulated phishing exercises.</li>
<li>Document ongoing education requirements.</li>
</ul>
<h2 id="20-appendix-b-evidence-pack-templates">20. Appendix B: Evidence Pack Templates<a class="headerlink" href="#20-appendix-b-evidence-pack-templates" title="Permanent link">&para;</a></h2>
<ul>
<li>Risk analysis report template with scope and methodology.</li>
<li>Control mapping matrix for HIPAA and GxP requirements.</li>
<li>Data flow diagram templates for PHI and R&amp;D data.</li>
<li>Vendor assessment questionnaire template.</li>
<li>Incident response tabletop exercise report template.</li>
<li>Backup and recovery test evidence template.</li>
<li>Asset inventory template for lab and OT equipment.</li>
<li>Change management log template for regulated systems.</li>
<li>Access review attestation template.</li>
<li>Executive summary template for board reporting.</li>
</ul>
<h2 id="21-appendix-c-source-map-and-notes">21. Appendix C: Source Map and Notes<a class="headerlink" href="#21-appendix-c-source-map-and-notes" title="Permanent link">&para;</a></h2>
<ul>
<li>Pharma/biotech premium data: <code>PAYSCALE_SECURITY_SALARY_RESEARCH_2025.md</code></li>
<li>Pharma/biotech median pay: <code>SECURITY_CONSULTING_SALARY_RESEARCH_2025.md</code></li>
<li>Healthcare rate benchmarks: <code>HEALTHCARE_SECURITY_CONSULTING_GUIDE_2025.md</code></li>
<li>HIPAA update signals: <code>CODEX_HEALTHCARE_10K.md</code></li>
<li>API security premium: <code>CODEX_API_SECURITY_10K.md</code></li>
<li>M&amp;A diligence premium: <code>CODEX_MA_DUEDILIGENCE_10K.md</code></li>
<li>GxP/IRB compliance references: <code>docs/PART3_PLATFORMS_TO_AVOID.md</code></li>
<li>Expert network life sciences rates: <code>REDDIT_EXPERT_NETWORK_COMPREHENSIVE_ANALYSIS_2025.md</code></li>
<li>Techspert life sciences specialization: <code>expert-network-research-2024-2025.json</code></li>
<li>Expert network life sciences notes: <code>List of Expert Consulting Platforms for Cybersecurity Professionals/MASTER_EXPERT_NETWORKS_COMPLETE_DOCUMENT.md</code></li>
<li>Life sciences platform notes: <code>List of Expert Consulting Platforms for Cybersecurity Professionals/COMPLETE_MERGED_EXPERT_NETWORKS_REPORT.md</code></li>
<li>Life sciences industries list: <code>List of Expert Consulting Platforms for Cybersecurity Professionals/pasted_content_2.txt</code></li>
<li>Clinical research GxP references: <code>List of Expert Consulting Platforms for Cybersecurity Professionals/research_expert_networks.csv</code></li>
<li>Biotech niche positioning: <code>EXPERT_NETWORK_COMPREHENSIVE_RESEARCH_2025.md</code></li>
<li>OT pharma manufacturing positioning: <code>CODEX_MANUFACTURING_ICS_5K.md</code></li>
<li>Pharma supply chain theft signal: <code>CODEX_LOGISTICS_SUPPLY_CHAIN_5K.md</code></li>
<li>IP protection references: <code>CODEX_AI_SECURITY_10K.md</code>, <code>CODEX_PRIVACY_10K.md</code>, <code>CODEX_SECURITY_ARCH_10K.md</code>, <code>CODEX_THREAT_INTEL_10K.md</code></li>
</ul>












                
              </article>
            </div>
          
          
  <script>var tabs=__md_get("__tabs");if(Array.isArray(tabs))e:for(var set of document.querySelectorAll(".tabbed-set")){var labels=set.querySelector(".tabbed-labels");for(var tab of tabs)for(var label of labels.getElementsByTagName("label"))if(label.innerText.trim()===tab){var input=document.getElementById(label.htmlFor);input.checked=!0;continue e}}</script>

<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
    
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
    <div class="md-copyright__highlight">
      Copyright &copy; 2025 Security Consulting Income Guide
    </div>
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/Ahmed-AdelB" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
    
    
    
    
      
      
    
    <a href="https://linkedin.com/in/yourprofile" target="_blank" rel="noopener" title="linkedin.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3M135.4 416H69V202.2h66.5V416zM102.2 96a38.5 38.5 0 1 1 0 77 38.5 38.5 0 1 1 0-77m282.1 320h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9z"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../../..", "features": ["navigation.instant", "navigation.tracking", "navigation.tabs", "navigation.tabs.sticky", "navigation.sections", "navigation.expand", "navigation.top", "navigation.footer", "search.suggest", "search.highlight", "search.share", "content.tabs.link", "content.code.copy", "content.code.annotate"], "search": "../../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
    
  </body>
</html>